R&D Rare disease and the women's health gap For women with rare diseases, they often face a double jeopardy, where many of the symptoms they experience can be confused with and misdiagnosed.
News Lundbeck preps for key bexicaserin data around year-end Lundbeck has completed patient randomisation in a pivotal trial of epilepsy candidate bexicaserin, one of its major growth hopes.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.